Hideki Nagao - 16 Jun 2022 Form 4 Insider Report for MEDICINOVA INC (MNOV)

Role
Director
Signature
/s/ Yuichi Iwaki, attorney-in-fact
Issuer symbol
MNOV
Transactions as of
16 Jun 2022
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 17:23:31 UTC
Previous filing
21 Jun 2021
Next filing
21 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNOV Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 16 Jun 2022 Common Stock 20,000 $2.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in four equal installments on September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023, subject to continued service with the Company.